Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Trial record 2 of 3 for:    chess lung

Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00365963
First received: August 16, 2006
Last updated: April 24, 2013
Last verified: April 2013
  Purpose

The purpose of this study is to find out if patients with lung cancer and their main informal caregiver (person providing physical, emotional, or financial support) are helped by getting information, support, and decision making tools through a computer system called CHESS(the Comprehensive Health Enhancement Support System)


Condition Intervention Phase
Non-Small Cell Lung Cancer
Device: Comprehensive Health Enhancement Support System
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Open Label
Official Title: Clinician Integration Study

Resource links provided by NLM:


Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:
  • Caregiver affect and adjustment [ Time Frame: 1 year post patient death ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Clinician-Patient-Caregiver Communication [ Time Frame: throughout study ] [ Designated as safety issue: No ]

Estimated Enrollment: 252
Study Start Date: April 2005
Study Completion Date: November 2011
Primary Completion Date: November 2011 (Final data collection date for primary outcome measure)
Intervention Details:
    Device: Comprehensive Health Enhancement Support System
    computer based support and education
Detailed Description:

Many patients and their family/friends use the internet for obtaining information regarding the cancer diagnosis and treatment. In this study, the main caregiver of patients with advance (stage III or IV) non-small cell lung cancer is provided with a computer and internet access. Approximately one-half of the participants will also receive CHESS.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Advanced Non-Small Cell Lung Cancer (Stage III or Stage IV)
  • Needs to have a "caregiver" - a spouse, partner, family member, or friend providing emotional, physical, and/or financial support - to participate with the patient.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00365963

Locations
United States, Wisconsin
University of Wisconsin- Madison 610 Walnut St, WARF 1109A
Madison, Wisconsin, United States, 53705
Sponsors and Collaborators
University of Wisconsin, Madison
Investigators
Principal Investigator: David H Gustafson, PhD Center for Health Systems Research and Analysis
  More Information

No publications provided by University of Wisconsin, Madison

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: University of Wisconsin, Madison
ClinicalTrials.gov Identifier: NCT00365963     History of Changes
Other Study ID Numbers: UW IRB #2003-191, NCI#5 P50 CA095817-03
Study First Received: August 16, 2006
Last Updated: April 24, 2013
Health Authority: United States: Federal Government

Keywords provided by University of Wisconsin, Madison:
lung cancer, caregivers, support, resources, education

Additional relevant MeSH terms:
Carcinoma, Non-Small-Cell Lung
Lung Neoplasms
Bronchial Neoplasms
Carcinoma, Bronchogenic
Lung Diseases
Neoplasms
Neoplasms by Site
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms

ClinicalTrials.gov processed this record on November 24, 2014